Whether MSI2 or MSI1, their expression levels in tumours are higher than those of corresponding normal tissues, and are related to tumour differentiation level, poor prognosis of patients, number of lymph node invasions and distant metastasis. This evidence concerns the gene MSI1 and neoplasm.